Research shows vitamin B12 deficiency is common in people with diabetes, highlighting the need for targeted screening and ...
We read with interest the Article by Marc P Bonaca and colleagues, which showed that the GLP-1 receptor agonist semaglutide improves walking distance by 13% in patients with peripheral artery disease ...
Somewhere along the way, we started treating constant discomfort as normal. Back pain that never really goes away. Headaches you pop a pill for and mo.
DEAR DR. ROACH: I am an 82-year old man who was in good health until I found out that I have an issue in my left kidney. My ...
Developed with IBSA’s innovative FilmTec® technology that dissolves in the mouth without the need for food or waterApproved in four dosage strengths (25, 50, 75, 100mg) for a tailored therapy to ...
IBSA USA, the U.S. subsidiary of the Swiss pharmaceutical company IBSA, announced today that the Food and Drug Administration (FDA) has approved VYBRIQUEtm, the first sildenafil oral film available to ...
Slower rates of sodium correction in hyponatremia may have gone too far in their attempts to prevent osmotic demyelination syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results